Literature DB >> 6214207

Prostaglandins and the immune response to cancer (review).

J Ceuppens, J Goodwin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6214207

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


× No keyword cloud information.
  7 in total

1.  The pattern of the mononuclear infiltrate as a prognostic parameter in flat superficial spreading melanomas.

Authors:  E B Bröcker; G Kolde; D Steinhausen; A Peters; E Macher
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

2.  Inhibition by indomethacin of spontaneous mammary tumorigenesis in SHN mice.

Authors:  H Nagasawa; T Naito
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

3.  Relationship of natural killer cytotoxicity to clinical and biochemical parameters of primary human breast cancer.

Authors:  A Fulton; G Heppner; L Roi; L Howard; J Russo; M Brennan
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

4.  Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

Authors:  D L Morton; L J Foshag; D S Hoon; J A Nizze; E Famatiga; L A Wanek; C Chang; D G Davtyan; R K Gupta; R Elashoff
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969

5.  Cancer cell progression and chemoimmunotherapy--dual effects in the induction of resistance to therapy.

Authors:  J Hamuro; T Kikuchi; F Takatsuki; M Suzuki
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

6.  Effects of cimetidine and indomethacin on the growth of dimethylhydrazine-induced or transplanted intestinal cancers in the rat.

Authors:  A Caignard; M Martin; D Reisser; B Thomas; F Martin
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

Review 7.  Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer.

Authors:  Xian-Zhong Ding; Rene Hennig; Thomas E Adrian
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.